10:00 – 16:00, 21st September 2022, The Royal Institution, London
We are delighted to announce our next in-person workshop focusing on how to build positive and equitable partnerships between patient groups and the life sciences industry
Collaborating with the pharmaceutical industry is often a key aim for rare disease patient groups looking to get involved in research or find funding partnerships.
For these collaborations to be successful, it’s essential that both parties understand each other’s needs and expectations.
During this workshop, we will hear from industry and patient group representatives who will discuss their successful projects, what they are looking for from collaboration, current barriers to partnerships and what they want to see in the future.
Presentations from Pharma, CRO and Patient Group representatives
Clear examples and guidance on how to make collaborations between patient groups and industry a success
Interactive activities and plenty of time to network with fellow attendees and speakers
A panel session with stakeholders from across the rare disease community where attendees will have the opportunity to ask questions
Talks that highlight the importance of collaboration between patient groups and the life sciences industry
Complimentary lunch and refreshments throughout
Global Patient Advocacy Lead
Speaker to be announced soon!
Watch this space as we will be announcing more workshop speakers and panellists very soon, including speakers from a CRO and rare disease Patient Group!
The workshop is taking place at The Royal Institution of Great Britain, 21 Albemarle Street, London, W1S 4BS.
Nearest tube stations:
Refreshments will be available throughout the day including tea, coffee and complimentary lunch.
Meat, fish and vegetarian options will be included as standard. Additional dietary needs can be met upon request. You can submit your catering requirements during the registration process.
Beacon will reimburse travel expenses for rare disease patients, carers, patient groups and charities, up to the total value of £75.00 per person. If your travel is likely to exceed this amount, please contact firstname.lastname@example.org ahead of the event so we can discuss whether further reimbursement will be possible.
All expenses, other than mileage, must be accompanied by valid receipts.
For further information on our expenses policy, please click here.
The venue has step-free access via a lift and/or ramp and accessible toilets onsite.
If you have any accessibility requirements, please note these on your registration form so we can ensure your needs are met.
To discuss any additional accessibility measures we can provide, please get in touch with our team at email@example.com.
The situation regarding COVID-19 is constantly changing. Our team will monitor this and determine the necessary protocols closer to the date of the workshop.
In any event, attendees can expect:
*Please note: given the current guidelines, delegates will be free to choose whether they wish to wear a face mask or not.
Ipsen’s vision is to be a leading global mid-size biopharmaceutical company, with a focus on transformative medicines in three key therapeutic areas: oncology, rare disease and neuroscience.